Nature Reviews Clinical Oncology (NRCO) is a scholarly journal dedicated to publishing research in the field of Medicine. Nature Publishing is the publisher of this esteemed journal. The P-ISSN assigned to Nature Reviews Clinical Oncology is 1759-4774 and its abbreviated form is Nat Rev Clin Oncol.
Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.
In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.
| Journal title | Nature Reviews Clinical Oncology (NRCO) |
| Abbreviation | Nat Rev Clin Oncol |
| Print ISSN | 1759-4774 |
| Online ISSN | 1759-4782 |
| Publisher Name | Nature Publishing |
| Editor-in-chief | Diana Romero, BSc, PhD |
| Subject Category | Medicine |
Nature Reviews Clinical Oncology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Nature Reviews Clinical Oncology Journal is Nat Rev Clin Oncol.
The Ranking of Nature Reviews Clinical Oncology in 2026 is 29. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Nature Reviews Clinical Oncology in 2026 is 82.7. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Nature Reviews Clinical Oncology in 2026 is 14.809. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The H-Index of Nature Reviews Clinical Oncology in 2026 is 198. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Nature Reviews Clinical Oncology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Nature Reviews Clinical Oncology is indexed in (Indexing details)
| PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
|---|---|---|---|---|---|
| ❌ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
| Abbreviation | Nat Rev Clin Oncol |
| Impact Factor | 82.7 |
| SJR | 14.809 |
| SNIP | 8.319 |
| Ranking | 29 |
| CiteScore | 75.5 |
| H-Index | 198 |
The Editor-in-chief of Nature Reviews Clinical Oncology is Diana Romero, BSc, PhD
Nature Reviews Clinical Oncology Call for paper : Nature Reviews Clinical Oncology invites original research contributions for consideration of publication in Nature Reviews Clinical Oncology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Nature Reviews Clinical Oncology involves the following steps:
No, the Nature Reviews Clinical Oncology journal is not indexed in PubMed.
Yes, the Nature Reviews Clinical Oncology journal is indexed in Scopus.
Yes, the Nature Reviews Clinical Oncology journal is indexed in UGC.
No, the Nature Reviews Clinical Oncology journal is not indexed in Index copernicus.
No, Nature Reviews Clinical Oncology journal is not a predatory journal.
The Impact Factor of the Nature Reviews Clinical Oncology is 82.7.
The Ranking of the Nature Reviews Clinical Oncology is 29.
Yes the Nature Reviews Clinical Oncology (NRCO) journal is a peer-reviewed journal.
Yes the Nature Reviews Clinical Oncology journal is a peer-reviewed journal and good to publish your paper.
Nature Reviews Clinical Oncology (NRCO) is a scholarly journal dedicated to publishing research in the field of Medicine. Nature Publishing is the publisher of this esteemed journal.
No, Nature Reviews Clinical Oncology is not a open access journal.